Results 1 to 10 of about 30,645 (194)

HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients [PDF]

open access: yesBMC Gastroenterology, 2023
Background Previous studies have indicated that HBV pregenome RNA (HBV pgRNA) could predict HBeAg seroconversion among the chronic hapatitis B (CHB) patients treated with pegylated interferon (Peg-IFN) or nucleos(t)ide analogues (NAs).
Guangjun Song   +6 more
doaj   +4 more sources

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment [PDF]

open access: yesEmerging Microbes and Infections, 2023
Indices for predicting HBsAg or HBeAg seroconversion in patients with chronic hepatitis B virus (HBV) infection during antiviral therapy remain elusive.
Shengxia Yin   +15 more
doaj   +4 more sources

Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated With Entecavir for 144 Weeks [PDF]

open access: yesInternational Journal of Infectious Diseases, 2020
Background: In some previous studies, serum hepatitis B virus RNA (HBV RNA) was proposed as an HBV viral marker during therapy. However, the dynamic change of HBV RNA, the correlation of HBV RNA with cccDNA, and the combination of HBV RNA with known HBV ...
Junqi Niu, Jie Wang, Mingxiang Zhang
exaly   +5 more sources

Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α [PDF]

open access: yesTherapeutic Advances in Gastroenterology
Background: As an uncommon serological pattern, the effect of hepatitis B e antigen/anti-hepatitis B e (HBeAg/anti-HBe) coexistence on peginterferon-α (Peg-IFN-α) therapy in patients with chronic hepatitis B (CHB) remains unknown.
Kaimin Song   +9 more
doaj   +4 more sources

Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy [PDF]

open access: yesScientific Reports, 2021
Tenofovir and entecavir are currently designated as the preferred oral antiviral drugs for chronic hepatitis B. However, only less than 40% of patients can achieve HBeAg seroconversion.
Yu-Li Zeng   +15 more
doaj   +2 more sources

Peripheral and intrahepatic B-cell subsets contribute to HBeAg seroconversion in patients with chronic hepatitis B [PDF]

open access: yesVirology Journal
The immunopathogenesis of chronic hepatitis B (CHB) with unclear immune phases hinders functional cure. For highly infectious HBeAg-positive (HBeAg+) patients where functional cure is unattainable, achieving sustained HBeAg seroconversion constitutes the
Jing Zuo   +6 more
doaj   +2 more sources

Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a [PDF]

open access: yesVirology Journal, 2019
Background Hepatitis B e antigen (HBeAg) seroconversion represents an endpoint of treatment of chronic hepatitis B virus (HBV) infections. Methods We have studied whether levels of serum hepatitis B virus ribonucleic acid (HBV RNA) during pegylated ...
Wen Jia   +8 more
doaj   +2 more sources

HBV-miR-3 is closely related to HBV replication and strongly predictive of HBeAg seroconversion in PegIFN-α treated patients [PDF]

open access: yesScientific Reports
HBV-miR-3 is encoded by HBV and takes part in pathogenesis of HBV-related liver disease. Whether HBV-miR-3 has a relationship with HBV replication and is predictive of PegIFN-α treatment response is still unknown. HBV-miR-3 quantification is based on qRT-
Zhenyu Xu   +6 more
doaj   +2 more sources

Plasma gamma-glutamylglycine predicts the seroconversion of hepatitis B e antigen in patients with chronic hepatitis B [PDF]

open access: yesFrontiers in Immunology
BackgroundThe seroconversion of hepatitis B e antigen (HBeAg) remains difficult to be completely obtained in the treatment of hepatitis B. This study aimed to characterize the metabolic signatures of HBeAg-positive patients and identify key metabolites ...
Ze-Hua Zhao   +11 more
doaj   +2 more sources

Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog [PDF]

open access: yesInfection and Drug Resistance, 2020
Xin Ji,* Muye Xia,* Bin Zhou, Shi Liu, GuiChan Liao, Shaohang Cai, Xiaoyong Zhang, Jie Peng State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang ...
Ji X   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy